These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9303697)

  • 1. [Correlation of inhibition of thrombocyte light chain myosin phosphorylation and thrombocyte aggregation by the new calcium and calmodulin antagonist].
    Aleksanian AR; Arutiunian NS; Galoian AA; Gerasimian DA
    Biull Eksp Biol Med; 1996 Jul; 122(7):40-2. PubMed ID: 9303697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of thrombocyte activation and possibilities of their pharmacological regulation].
    Razumov VB; Gutkin AB; Omel'ianovskiĭ VV
    Kardiologiia; 1988 May; 28(5):118-22. PubMed ID: 2842536
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of calcium antagonists on thrombocyte aggregation].
    Lakin KM; Manevich EM; Muliar AG; Mironiuk EP; Novikova NV
    Farmakol Toksikol; 1987; 50(5):78-88. PubMed ID: 2826225
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of calcium-channel blockers on human thrombocyte aggregation induced by alpha-adrenoreceptor agonists].
    Ivleva AIa; Kobalava ZhD; Moiseev VS
    Farmakol Toksikol; 1989; 52(2):77-80. PubMed ID: 2568273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of haloperidol and chlorpromazine on smooth muscle contractility, platelet aggregation and neuronal calcium current.
    Prokopenko RA; Mogilevich SE; Luik AI; Naydyenova IY; Batrak GN; Hawryluk BR; Degtiar VY
    Gen Physiol Biophys; 1995 Aug; 14(4):349-57. PubMed ID: 8720698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the calmodulin antagonist trifluoperazine on stimulus-induced calcium mobilization, aggregation, secretion, and protein phosphorylation in platelets.
    Feinstein MB; Hadjian RA
    Mol Pharmacol; 1982 Mar; 21(2):422-31. PubMed ID: 7099144
    [No Abstract]   [Full Text] [Related]  

  • 7. The characterization of Ca(2+)-calmodulin independent phosphorylation of myosin light chains by a fragment from myosin light chain kinase.
    Yang JX; Wang XM; Tang ZY; Chen H; Xu H; Lin Y
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):793-800. PubMed ID: 12958650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionized calcium as an intracellular messenger in blood platelets.
    Salzman EW; Ware JA
    Prog Hemost Thromb; 1989; 9():177-202. PubMed ID: 2643816
    [No Abstract]   [Full Text] [Related]  

  • 9. Calmodulin-myosin light chain kinase inhibition changes fibroblast-populated collagen lattice contraction, cell migration, focal adhesion formation, and wound contraction.
    Levinson H; Moyer KE; Saggers GC; Ehrlich HP
    Wound Repair Regen; 2004; 12(5):505-11. PubMed ID: 15453832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical model of the interactions between Ca2+, calmodulin and myosin light chain kinase.
    Fajmut A; Brumen M; Schuster S
    FEBS Lett; 2005 Aug; 579(20):4361-6. PubMed ID: 16051224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin inhibitors and calcium channel blockers influence dideoxycytidine renal excretion.
    Enigbokan MA; West D; Preston J; Thompson JO
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S15-8. PubMed ID: 8574143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction and regulatory myosin light chain.
    Akiyama K; Akopian G; Jinadasa P; Gluckman TL; Terhakopian A; Massey B; Bing RJ
    J Mol Cell Cardiol; 1997 Oct; 29(10):2641-52. PubMed ID: 9344759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostanoid F receptors elicit an inotropic effect in rat left ventricle by enhancing myosin light chain phosphorylation.
    Riise J; Nguyen CH; Qvigstad E; Sandnes DL; Osnes JB; Skomedal T; Levy FO; Krobert KA
    Cardiovasc Res; 2008 Dec; 80(3):407-15. PubMed ID: 18703533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin-induced phosphorylation of myosin light chain is mediated by extracellular calcium influx in pregnant rat myometrium.
    Shojo H; Kaneko Y
    J Mol Recognit; 2001; 14(6):401-5. PubMed ID: 11757073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
    Saeed SA; Rasheed H
    Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered myosin light-chain phosphorylation in resting platelets from premenopausal women with diabetes.
    Guzmán CB; Walsh M; Reddy V; Donthireddy V; Mahmood F; Bode A; Turner JR; Jacober SJ; Sowers JR
    Metabolism; 2001 Feb; 50(2):151-6. PubMed ID: 11229421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-induced activation of RhoA in platelet shape change.
    Bodie SL; Ford I; Greaves M; Nixon GF
    Biochem Biophys Res Commun; 2001 Sep; 287(1):71-6. PubMed ID: 11549255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in interfilament spacing mimic the effects of myosin regulatory light chain phosphorylation in rabbit psoas fibers.
    Yang Z; Stull JT; Levine RJ; Sweeney HL
    J Struct Biol; 1998; 122(1-2):139-48. PubMed ID: 9724615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMN-709, a chlorobenzenesulfonamide derivative, is a new membrane-permeable calmodulin antagonist.
    Yokokura H; Okada Y; Terada O; Hidaka H
    Jpn J Pharmacol; 1996 Oct; 72(2):127-35. PubMed ID: 8912914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligustrazine, allicin and shear-induced platelet aggregation.
    Liao F; Jiao L
    Clin Hemorheol Microcirc; 2000; 22(2):167-8. PubMed ID: 10831067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.